Connection

STEPHEN FADEM to Kidney Failure, Chronic

This is a "connection" page, showing publications STEPHEN FADEM has written about Kidney Failure, Chronic.
Connection Strength

1.122
  1. Dialysis, Transplantation, and Work: Honoring Original Intent. Clin J Am Soc Nephrol. 2022 10; 17(10):1431-1432.
    View in: PubMed
    Score: 0.427
  2. Satisfaction with renal replacement therapy and education: the American Association of Kidney Patients survey. Clin J Am Soc Nephrol. 2011 Mar; 6(3):605-12.
    View in: PubMed
    Score: 0.191
  3. The role of serum phosphate control in supporting transplant readiness in?patients on dialysis. Curr Med Res Opin. 2025 Sep; 41(9):1665-1668.
    View in: PubMed
    Score: 0.131
  4. Helping patients, renal staff gain access to information. Nephrol News Issues. 1998 Apr; 12(4):38-9.
    View in: PubMed
    Score: 0.078
  5. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial. Am J Kidney Dis. 2015 Sep; 66(3):479-88.
    View in: PubMed
    Score: 0.064
  6. Converting hemodialysis patients from intravenous paricalcitol to intravenous doxercalciferol - a dose equivalency and titration study. Clin Nephrol. 2008 Oct; 70(4):319-24.
    View in: PubMed
    Score: 0.040
  7. The Physician Quality Reporting Initiative: a practical approach to implementing quality reporting. Adv Chronic Kidney Dis. 2008 Jan; 15(1):56-63.
    View in: PubMed
    Score: 0.038
  8. Management of chronic kidney disease mineral-bone disorder. Adv Chronic Kidney Dis. 2007 Jan; 14(1):44-53.
    View in: PubMed
    Score: 0.036
  9. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis. 2006 Feb; 47(2):263-76.
    View in: PubMed
    Score: 0.034
  10. Static intra-access pressure ratio does not correlate with access blood flow. Kidney Int. 2004 Oct; 66(4):1512-6.
    View in: PubMed
    Score: 0.031
  11. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int. 2002 May; 61(5):1830-9.
    View in: PubMed
    Score: 0.026
  12. Use of saralasin in end-stage renal disease. Kidney Int Suppl. 1979 Mar; (9):S93-100.
    View in: PubMed
    Score: 0.021
  13. Gastrointestinal blood loss in patients with chronic renal failure. Am J Kidney Dis. 1982 Jan; 1(4):232-6.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.